Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Oulhen · SciRah

Researcher profile · Semantic Scholar

M. Oulhen

Share profile

M. Oulhen — researcher profile on SciRah

h-index: 16
Works: 42
Citations: 1,158

Most-cited papers

Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer.
Emma Pailler, J. Adam, A. Barthélémy, M. Oulhen +10 more
2013Journal of Clinical Oncology279 citations Open access
Semantic Scholar
CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs)
Tala Tayoun, V. Faugeroux, M. Oulhen, A. Aberlenc +2 more
2019Cells112 citations Open access
Semantic Scholar
Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non–Small-Cell Lung Cancer
Emma Pailler, V. Faugeroux, M. Oulhen, L. Mezquita +12 more
2019Clinical Cancer Research109 citations
Semantic Scholar
Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap)
K. Andree, A. Mentink, L. Zeune, L. Terstappen +25 more
2018International Journal of Cancer78 citations Open access
Semantic Scholar
Circulating Tumor Cells in Lung Cancer
R. Young, Emma Pailler, F. Billiot, F. Drusch +6 more
2012Acta Cytologica73 citations
Semantic Scholar
Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model
V. Faugeroux, Emma Pailler, M. Oulhen, O. Déas +18 more
2020Nature Communications66 citations Open access
Semantic Scholar
Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testing
P. Pawlikowska, Tala Tayoun, M. Oulhen, V. Faugeroux +11 more
2020Scientific Reports62 citations Open access
Semantic Scholar
Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK-Rearranged Non-Small Cell Lung Cancer Patients.
Emma Pailler, M. Oulhen, I. Borget, J. Remon +10 more
2017Cancer Research58 citations
Semantic Scholar
Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castrationresistant prostate cancer: a report from the PETRUS prospective study
C. Massard, M. Oulhen, S. Le Moulec, N. Auger +9 more
2016OncoTarget36 citations Open access
Semantic Scholar
Proficiency Testing to Assess Technical Performance for CTC-Processing and Detection Methods in CANCER-ID.
R. Neves, W. Ammerlaan, K. Andree, S. Bender +16 more
2021Clinical Chemistry35 citations Open access
Semantic Scholar
Patritumab deruxtecan in HR+HER2− advanced breast cancer: a phase 2 trial
B. Pistilli, F. Mosele, Noemie Corcos, L. Pierotti +42 more
2025Nature Medicine32 citations Open access
Semantic Scholar
An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer.
V. Faugeroux, C. Lefebvre, Emma Pailler, V. Pierron +17 more
2020European Urology Oncology31 citations Open access
Semantic Scholar
Circulating tumor cells (CTCs) for the noninvasive monitoring and personalization of non-small cell lung cancer (NSCLC) therapies.
P. Pawlikowska, V. Faugeroux, M. Oulhen, A. Aberlenc +3 more
2019Journal of Thoracic Disease31 citations Open access
Semantic Scholar
Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
M. Oulhen, P. Pawlikowska, Tala Tayoun, Marianna Garonzi +11 more
2021npj Precision Oncology27 citations Open access
Semantic Scholar
Method for semi-automated microscopy of filtration-enriched circulating tumor cells
Emma Pailler, M. Oulhen, F. Billiot, A. Galland +11 more
2016BMC Cancer27 citations Open access
Semantic Scholar
The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer
K. Ross, Emma Pailler, V. Faugeroux, Mélissa Taylor +8 more
2015Expert Review of Molecular Diagnostics24 citations
Semantic Scholar
Targeting genome integrity dysfunctions impedes metastatic potency in non–small cell lung cancer circulating tumor cell–derived explants
Tala Tayoun, V. Faugeroux, M. Oulhen, O. Déas +14 more
2022JCI Insight16 citations Open access
Semantic Scholar
Detection of Gene Rearrangements in Circulating Tumor Cells: Examples of ALK-, ROS1-, RET-Rearrangements in Non-Small-Cell Lung Cancer and ERG-Rearrangements in Prostate Cancer.
C. Catelain, Emma Pailler, M. Oulhen, V. Faugeroux +2 more
2017Advances in Experimental Medicine and Biology15 citations
Semantic Scholar
Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer-ready for prime-time?
Emma Pailler, V. Faugeroux, M. Oulhen, C. Catelain +1 more
2017Translational Lung Cancer Research15 citations Open access
Semantic Scholar
Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 study.
D. Planchard, N. Cozic, M. F. Mosele, Noemie Corcos +43 more
2026Cancer Cell11 citations Open access
Semantic Scholar
Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer
L. Mezquita, M. Oulhen, A. Aberlenc, M. Deloger +8 more
2024British Journal of Cancer10 citations Open access
Semantic Scholar
Tumor Evolution and Therapeutic Choice Seen through a Prism of Circulating Tumor Cell Genomic Instability
Tala Tayoun, M. Oulhen, A. Aberlenc, F. Farace +1 more
2021Cells7 citations Open access
Semantic Scholar
Analysis of single circulating tumor cells (CTCs) to identify resistance mutations to ALK-inhibitors in both ALK-gene and bypass oncogenic pathways.
Emma Pailler, L. Mezquita, V. Faugeroux, M. Oulhen +15 more
20183 citations
Semantic Scholar
Abstract P2-08-27: ICARUS-BREAST02: Safety, Tolerability, & Anti-tumor Activity of patritumab deruxtecan (HER3-DXd) monotherapy & combinations in patients (pts) with inoperable advanced breast cancer (ABC) following progression on trastuzumab deruxtecan (T-DXd)
B. Pistilli, S. Michiels, Rasha Cheikh-Hussin, M. Lacroix-Triki +17 more
2025Clinical Cancer Research2 citations
Semantic Scholar
Abstract 3787: EpCAM- and EpCAM+ circulating tumor cells in metastatic prostate and breast cancer patients: a multicenter study
S. de Wit, K. Andree, J. Swennenhuis, E. Rossi +19 more
20172 citations
Semantic Scholar
Abstract 1951: Circulating tumor cell-derived explant models reveal DNA damage response-based therapeutic opportunities in non-small cell lung cancer
Tala Tayoun, V. Faugeroux, M. Oulhen, O. Déas +14 more
2022Cancer Research1 citations
Semantic Scholar
Abstract 1723: Diagnostic leukapheresis results in a significant increase in CTC yield in metastatic breast and prostate cancer
K. Andree, A. Mentink, J. Swennenhuis, L. Terstappen +23 more
20171 citations
Semantic Scholar
Isolation and Sequencing of Single Circulating Tumor Cells.
M. Oulhen, M. V. Sanchez-Becerra, P. Pawlikowska, F. Farace
2026Methods in molecular biology0 citations
Semantic Scholar
Abstract P2-10-28: COMPASS-TNBC - A phase Ib/II, open-label, modular, dose-finding and dose-expansion study to explore safety and anti-tumor activity of novel therapeutics in patients with early relapsed mTNBC. Module 1: Dato-DXd & Module 2: Dato-DXd + durvalumab
T. Grinda, Rasha Cheikh-Hussin, M. Lacroix-Triki, K. Serhal +19 more
2025Clinical Cancer Research0 citations
Semantic Scholar
190eP EF-FACS circulating tumor cells (CTC) detection complements circulating tumor DNA (ctDNA)-based prognostic stratification of non-small cell lung cancer (NSCLC) patients
M. V. Sanchez-Becerra, M. Oulhen, D. Drubay, J. R. Masip +13 more
2025Annals of Oncology0 citations Open access
Semantic Scholar
Abstract 598: Resistance mechanisms to BRAF inhibition identified by single circulating tumor cell and cell-free tumor DNA molecular profiling inBRAF-mutant non-small cell lung cancer
L. Mezquita, M. Oulhen, A. Aberlenc, M. Deloger +15 more
2021Clinical research0 citations
Semantic Scholar
Abstract 595: Patterns and dynamics of genome instability drive metastatic activity in non-small cell lung cancer (NSCLC) circulating tumor cell (CTC)-derived xenograft (CDX) models
Tala Tayoun, V. Faugeroux, M. Oulhen, Emma Pailler +15 more
2021Clinical research0 citations
Semantic Scholar
Abstract 3654: Identification of resistance mutations to crizotinib through circulating tumor cell (CTC) analysis inALK-rearranged non-small-cell lung cancer (NSCLC)
Emma Pailler, V. Faugeroux, M. Oulhen, C. Forcato +12 more
2018Clinical research0 citations
Semantic Scholar
Filter-Adapted Fluorescent In Situ Hybridization (FA-FISH) for Filtration-Enriched Circulating Tumor Cells.
M. Oulhen, Emma Pailler, V. Faugeroux, F. Farace
2017Methods in molecular biology0 citations
Semantic Scholar
ALK-amplified circulating tumor cells as a surrogate marker for crizotinib benefit in ALK-rearranged non-small cell lung cancer patients.
Emma Pailler, J. Remon, M. Oulhen, I. Borget +8 more
20160 citations
Semantic Scholar
Abstract 856: Number of ALK-amplified circulating tumor cells predicts progression-free survival in ALK-rearranged non-small cell lung cancer patients treated by crizotinib
Emma Pailler, M. Oulhen, K. Ross, F. Billiot +8 more
20160 citations
Semantic Scholar
Molecular characterization of heterogeneity in circulating tumor cells (CTCs) and tumor samples of metastatic castration-resistant prostate cancer (mCRPC) patients: The multicenter PETRUS program.
C. Massard, M. Oulhen, S. Le Moulec, Y. Loriot +9 more
20150 citations
Semantic Scholar
Abstract 3079: Characterization of the molecular heterogeneity of circulating tumor cells in metastatic prostate cancer
C. Massard, M. Oulhen, A. Valent, S. Le Moulec +3 more
20130 citations
Semantic Scholar
Abstract 1470: Detection of circulating tumor cells harboring a uniqueALKrearrangement inALK-positive non-small cell lung cancer.
Emma Pailler, J. Adam, A. Barthélémy, M. Oulhen +10 more
20130 citations
Semantic Scholar
Contents Vol. 56,2012
Lindsey E. Kane, R. Root, J. Voss, Jill L. Caudill +56 more
2012Acta Cytologica0 citations Open access
Semantic Scholar
Subject Index Vol. 56,2012
Lindsey E. Kane, R. Root, J. Voss, Jill L. Caudill +56 more
2012Acta Cytologica0 citations
Semantic Scholar
Méthode de caractérisât! on de cellules tumorales circulantes et application au diagnostic
A. Barthelemy, F. Farace, M. Oulhen, A. Valent +2 more
20120 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Farace×35
Invite
F. Farace — researcher profile on SciRah
Emma Pailler×20
Invite
Emma Pailler — researcher profile on SciRah
B. Besse×20
Invite
B. Besse — researcher profile on SciRah
V. Faugeroux×18
Invite
V. Faugeroux — researcher profile on SciRah

×17

Invite

D. Planchard — researcher profile on SciRah

Invite

J. Soria — researcher profile on SciRah

Invite

P. Vielh — researcher profile on SciRah

A. Aberlenc×11

Invite

A. Aberlenc — researcher profile on SciRah

Invite

N. Auger — researcher profile on SciRah

P. Pawlikowska×9

Invite

P. Pawlikowska — researcher profile on SciRah

Invite

F. Billiot — researcher profile on SciRah

Invite

Tala Tayoun — researcher profile on SciRah